Yunion

Yunion Bio is a biotechnology company specializing in the development of extracellular vesicle (EV) based therapeutics and delivery systems. The company leverages its proprietary Y-EV platform to engineer exosomes for the targeted delivery of diverse payloads, including mRNA, functional proteins, and small molecules. Yunion's technology aims to overcome traditional delivery barriers, enhancing the stability and tissue-specific uptake of therapeutic agents while reducing immunogenicity. Their research and development pipeline primarily focuses on oncology, inflammatory diseases, and rare genetic disorders. By utilizing naturally occurring vesicles, Yunion Bio seeks to provide a safer and more efficient alternative to synthetic lipid nanoparticles for advanced therapies.